[A moderate intrauterine growth delay with lethal outcome: neonatal Menkes disease]

B Veit-Sauca1, G Cambonie, R Salloum

  • 1Service de néonatologie et réanimation néonatale, pédiatrie 2, hôpital Arnaud-de-Villeneuve, CHU de Montpellier, Montpellier, France.

Insights

Menkes disease, a rare X-linked disorder affecting copper transport, can cause severe symptoms including skull fractures and subdural hematomas in newborns. Early diagnosis is crucial for managing this severe condition.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Menkes disease is a rare X-linked recessive disorder.
  • It involves impaired copper transport and subsequent enzyme deficiencies.
  • This leads to a wide range of clinical manifestations.

Observation:

  • A case of intrauterine growth delay with congenital skull fracture and subdural hematoma is presented.
  • Diagnosis was confirmed in the neonatal period.
  • Absorptiometry revealed global osteopenia.

Findings:

  • The patient's symptoms were consistent with Menkes disease.
  • The underlying defect is reduced copper incorporation into essential enzymes.
  • Neurological, bone, and vascular abnormalities are characteristic.

Implications:

  • This case highlights the severe presentation of Menkes disease in neonates.
  • Understanding copper transport defects is key to diagnosing and managing this condition.
  • Early identification is critical due to the typically poor prognosis, with death often occurring before age five.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...